Literature DB >> 30707928

Involvement of AMP-activated protein kinase in neuroinflammation and neurodegeneration in the adult and developing brain.

Mariko Saito1,2, Mitsuo Saito3, Bhaskar C Das4.   

Abstract

Microglial activation followed by neuroinflammation is a defense mechanism of the brain to eliminate harmful endogenous and exogenous materials including pathogens and damaged tissues, while excessive or chronic neuroinflammation may cause or exacerbate neurodegeneration observed in brain injuries and neurodegenerative diseases. Depending on conditions/environments during activation, microglia acquire distinct phenotypes, such as pro-inflammatory, anti-inflammatory, and disease-associated phenotypes, and show their ability to phagocytose various objects and produce pro-and anti-inflammatory mediators. Prevention of excessive inflammation by regulating the microglia's pro/anti-inflammatory balance is important for alleviating progression of brain injuries and diseases. Among many factors involved in the regulation of microglial phenotypes, cellular energy status plays an important role. Adenosine monophosphate-activated protein kinase (AMPK), which serves as a master sensor and regulator of energy balance, is considered a candidate molecule. Accumulating evidence from adult rodent studies indicates that AMPK activation promotes anti-inflammatory responses in microglia exposed to danger signals or various stressors mainly through inhibition of the nuclear factor κB (NF-κB) signaling and activation of the nuclear factor erythroid-2-related factor-2 (Nrf2) pathway. However, AMPK activation in neurons exposed to stressors/insults may exacerbate neuronal damage if AMPK activation is excessive or prolonged. While AMPK affects microglial activation states and neuronal cell survival rates in both the adult and the developing brain, studies in the developing brain are still scarce, even though activated AMPK is highly expressed especially in the neonatal brain. More in depth studies in the developing brain are important, because neuroinflammation/neurodegeneration occurred during development can result in long-lasting brain damage.
Copyright © 2019 ISDN. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMPK; Developing brain; Inflammation; Microglia; NF-kB; Neuroprotection

Mesh:

Substances:

Year:  2019        PMID: 30707928      PMCID: PMC6663660          DOI: 10.1016/j.ijdevneu.2019.01.007

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  10 in total

1.  MicroRNA-124 modulates neuroinflammation in acute methanol poisoning rats via targeting Krüppel-like factor-6.

Authors:  Shu Zhou; Jinjun Li; XiaoNa Zhang; Wen Xiong
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Retinol-binding protein 4 in combination with lipids to predict the regression phenomenon of autism spectrum disorders.

Authors:  Jianling Chen; Jing Chen; Yun Xu; Peipei Cheng; Shunying Yu; Yingmei Fu; Yasong Du
Journal:  Lipids Health Dis       Date:  2021-08-26       Impact factor: 3.876

3.  Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells.

Authors:  Valentino Racki; Marina Marcelic; Igor Stimac; Daniela Petric; Natalia Kucic
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

4.  Neurological Enhancement Effects of Melatonin against Brain Injury-Induced Oxidative Stress, Neuroinflammation, and Neurodegeneration via AMPK/CREB Signaling.

Authors:  Shafiq Ur Rehman; Muhammad Ikram; Najeeb Ullah; Sayed Ibrar Alam; Hyun Young Park; Haroon Badshah; Kyonghwan Choe; Myeong Ok Kim
Journal:  Cells       Date:  2019-07-21       Impact factor: 6.600

5.  Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice.

Authors:  Andrea Stojakovic; Sergey Trushin; Anthony Sheu; Layla Khalili; Su-Youne Chang; Xing Li; Trace Christensen; Jeffrey L Salisbury; Rachel E Geroux; Benjamin Gateno; Padraig J Flannery; Mrunal Dehankar; Cory C Funk; Jordan Wilkins; Anna Stepanova; Tara O'Hagan; Alexander Galkin; Jarred Nesbitt; Xiujuan Zhu; Utkarsh Tripathi; Slobodan Macura; Tamar Tchkonia; Tamar Pirtskhalava; James L Kirkland; Rachel A Kudgus; Renee A Schoon; Joel M Reid; Yu Yamazaki; Takahisa Kanekiyo; Song Zhang; Emirhan Nemutlu; Petras Dzeja; Adam Jaspersen; Ye In Christopher Kwon; Michael K Lee; Eugenia Trushina
Journal:  Commun Biol       Date:  2021-01-08

Review 6.  Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment.

Authors:  Marianna Gabriella Rispoli; Silvia Valentinuzzi; Giovanna De Luca; Piero Del Boccio; Luca Federici; Maria Di Ioia; Anna Digiovanni; Eleonora Agata Grasso; Valeria Pozzilli; Alessandro Villani; Antonio Maria Chiarelli; Marco Onofrj; Richard G Wise; Damiana Pieragostino; Valentina Tomassini
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

7.  Bisphenol a Induces Autophagy Defects and AIF-Dependent Apoptosis via HO-1 and AMPK to Degenerate N2a Neurons.

Authors:  Ching-Tien Lee; Cheng-Fang Hsieh; Jiz-Yuh Wang
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

8.  Wnt family member 1 (Wnt1) overexpression-induced M2 polarization of microglia alleviates inflammation-sensitized neonatal brain injuries.

Authors:  Jinzhi Gao; Hao Xu; Zhihui Rong; Ling Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 9.  Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?

Authors:  Kufreobong E Inyang; Joseph K Folger; Geoffroy Laumet
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-26       Impact factor: 4.147

Review 10.  Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

Authors:  Raquel García-García; Laura Martín-Herrero; Laura Blanca-Pariente; Jesús Pérez-Cabello; Cintia Roodveldt
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.